- Intensified competition for human resources
- Mismatch between wellness programs and customer needs
- Exacerbated climate disasters
- Stricter environmental regulations
- Delay or failure in digital transformation
- Augmented monitoring costs due to business and supply chain expansion
株式会社新日本科学 SHIN NIPPON BIOMEDICAL LABORATORIES, LTD.
Greenhouse gas emissions & sustainability report data
In its 2022-04 to 2023-03 reporting, 株式会社新日本科学 SHIN NIPPON BIOMEDICAL LABORATORIES, LTD. disclosed greenhouse gas emissions of 14.6K t-CO2e (Scope 1&2). By scope: Scope 1: 5.4K t-CO2e; Scope 2: 9.2K t-CO2e; Scope 3: 312 t-CO2e. Figures are as stated in the company's own report and may use different boundaries, units or methods (for example market-based vs location-based Scope 2), so compare with care.
GHG Emissions
14.6K t-CO2e (Scope 1&2)
2022-04 to 2023-03
Water Usage
1.2M m3
2022-04 to 2023-03
Waste
287.6 tons
2022-04 to 2023-03
Energy Use
24.4K MWh
2022-04 to 2023-03
📊 Emissions by Scope (2022-04 to 2023-03)
| Scope | What it covers | Reported value |
|---|---|---|
| Scope 1 | Direct emissions from sources the company owns or controls (fuel combustion, company vehicles, process and fugitive emissions). | 5.4K t-CO2e |
| Scope 2 | Indirect emissions from purchased electricity, steam, heat and cooling. | 9.2K t-CO2e |
| Scope 3 | Other indirect emissions across the value chain (purchased goods, business travel, use of sold products, etc.). | 312 t-CO2e |
New to scopes? Read Scope 1, 2 and 3 emissions explained and market-based vs location-based Scope 2.
📈 Emissions by Report Period
| Report period | Headline emissions figure reported |
|---|---|
| 2022-04 to 2023-03 | 14.6K t-CO2e (Scope 1&2) |
| 2021 | 10.8K tCO2e/year (FY2020) |
Each row is the headline figure extracted from a different report; scope coverage and methodology can change between years.
✅ Reported Environmental Achievements
- Achieved carbon neutrality in Scopes 1 and 2 emissions in domestic business activities by FY2030 (target)
- Reduced CO2 emissions per revenue (CO2 carbon intensity) from 0.72 t-CO2/million yen in FY2021 to 0.58 t-CO2/million yen in FY2023
- Increased CO2 environmental efficiency (revenue/CO2 emissions) from 1.40 million yen/t-CO2 in FY2021 to 1.72 million yen/t-CO2 in FY2023
- Planted 62,480 trees in 37ha by the end of 2023 as part of sustainable forest management
- Reduced paper resource usage by 1.2 million sheets (33%) in FY2023 compared to FY2021
🎯 Climate & Sustainability Targets
🔜 Short-term
- Reduce water consumption (target not specified)
📅 Medium-term
- Achieve carbon neutrality in Scopes 1 and 2 emissions in domestic business activities by FY2030
- Increase percentage of women in management positions to 30% or more by March 2029
🔭 Long-term
- Net zero emissions (target year not specified)
🌱 ESG Focus Areas
Supporting Drug Development and Improving Medical TechnologyWellbeing LifestylePreserving the Beautiful Natural EnvironmentCreating an Organization Where People can Enjoy Their WorkEvolving the Business through Digital Transformation and Robotic Process AutomationEnhancing Stakeholder EngagementBuilding a Governance Framework for Realizing the Corporate Principles